Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction

This publication has 22 references indexed in Scilit:

• Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction
  European Heart Journal, 1997
• Heart failure: Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands
  European Heart Journal, 1996
• Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
  1996
• Cost-effectiveness analysis: are the outputs worth the inputs?
  1996
• The clinical-economic trial: Promise, problems, and challenges
  Controlled Clinical Trials, 1995
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Is the Use of t-PA as Compared with Streptokinase Cost Effective?
  New England Journal of Medicine, 1995
• Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction
  New England Journal of Medicine, 1995
• GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.
  1994
• A Clinician's Guide to Cost-Effectiveness Analysis
  Annals of Internal Medicine, 1990